diazooxonorleucine and gemcitabine

diazooxonorleucine has been researched along with gemcitabine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brentnall, TA; Chen, R; Jung, L; Lai, LA; Pan, S; Pillarisetty, VG; Riddell, J; Sullivan, Y; Wang, L; Wong, M	1

Other Studies

1 other study(ies) available for diazooxonorleucine and gemcitabine

Article	Year
Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer. Scientific reports, 2017, 08-11, Volume: 7, Issue:1 Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Diazooxonorleucine; Drug Resistance, Neoplasm; Drug Synergism; Gemcitabine; Glutamine; Humans; Metabolic Networks and Pathways; Oxidation-Reduction; Pancreatic Neoplasms; Proteomics	2017

Article

Year

Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer.

Scientific reports, 2017, 08-11, Volume: 7, Issue:1

Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Diazooxonorleucine; Drug Resistance, Neoplasm; Drug Synergism; Gemcitabine; Glutamine; Humans; Metabolic Networks and Pathways; Oxidation-Reduction; Pancreatic Neoplasms; Proteomics

2017